Back to search

High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200

Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol, P J O’Dwyer, Edith P. Mitchell
DOI: 10.1200/jco.2005.23.16_suppl.2
Journal of Clinical Oncology

Data up to Jan 2025

Published2005
Citations347
References0
Fields
MedicineInternal medicineOncologyGastroenterology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated… (2005) – Journal of Clinical Oncology | Metascience Observatory Explorer